MAZE logo

Maze Therapeutics, Inc. (MAZE) Cash from operations

annual CFO:

$75.95M+$162.78M(+187.48%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MAZE annual cash flow from operations is $75.95 million, with the most recent change of +$162.78 million (+187.48%) on December 31, 2024.
  • During the last 3 years, MAZE annual CFO has risen by +$175.16 million (+176.56%).
  • MAZE annual CFO is now at all-time high.

Performance

MAZE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEcash flow metrics

quarterly CFO:

-$30.05M-$536.00K(-1.82%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE quarterly cash flow from operations is -$30.05 million, with the most recent change of -$536.00 thousand (-1.82%) on June 30, 2025.
  • Over the past year, MAZE quarterly CFO has dropped by -$175.10 million (-120.72%).
  • MAZE quarterly CFO is now -120.72% below its all-time high of $145.05 million, reached on June 30, 2024.

Performance

MAZE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEcash flow metrics

TTM CFO:

-$82.02M-$175.10M(-188.12%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE TTM cash flow from operations is -$82.02 million, with the most recent change of -$175.10 million (-188.12%) on June 30, 2025.
  • Over the past year, MAZE TTM CFO has dropped by -$116.80 million (-335.80%).
  • MAZE TTM CFO is now -182.72% below its all-time high of $99.16 million, reached on December 31, 2024.

Performance

MAZE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MAZE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+187.5%-120.7%-335.8%
3 y3 years+176.6%+54.6%-23.9%
5 y5 years+176.6%+54.6%-23.9%

MAZE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+176.6%-120.7%+54.6%-182.7%+25.6%
5 y5-yearat high+176.6%-120.7%+54.6%-182.7%+25.6%
alltimeall timeat high+176.6%-120.7%+54.6%-182.7%+25.6%

MAZE Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$30.05M(+1.8%)
-$82.02M(-188.1%)
Mar 2025
-
-$29.52M(+31.5%)
$93.08M(-6.1%)
Dec 2024
$75.95M
-$22.45M(-115.5%)
$99.16M(+185.1%)
Jun 2024
-
$145.05M(-718.9%)
$34.78M(-131.5%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$23.44M(+13.5%)
-$110.26M(+27.0%)
Dec 2023
-$86.83M(-12.5%)
-$20.64M(-68.8%)
-$86.83M(+31.2%)
Sep 2023
-
-$66.18M
-$66.18M
Dec 2022
-$99.20M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual CFO year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly CFO year-on-year change?
  • What is Maze Therapeutics, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM CFO year-on-year change?

What is Maze Therapeutics, Inc. annual cash flow from operations?

The current annual CFO of MAZE is $75.95M

What is the all time high annual CFO for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual cash flow from operations is $75.95M

What is Maze Therapeutics, Inc. annual CFO year-on-year change?

Over the past year, MAZE annual cash flow from operations has changed by +$162.78M (+187.48%)

What is Maze Therapeutics, Inc. quarterly cash flow from operations?

The current quarterly CFO of MAZE is -$30.05M

What is the all time high quarterly CFO for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly cash flow from operations is $145.05M

What is Maze Therapeutics, Inc. quarterly CFO year-on-year change?

Over the past year, MAZE quarterly cash flow from operations has changed by -$175.10M (-120.72%)

What is Maze Therapeutics, Inc. TTM cash flow from operations?

The current TTM CFO of MAZE is -$82.02M

What is the all time high TTM CFO for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM cash flow from operations is $99.16M

What is Maze Therapeutics, Inc. TTM CFO year-on-year change?

Over the past year, MAZE TTM cash flow from operations has changed by -$116.80M (-335.80%)
On this page